Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives
Article in Frontiers in Immunology (April 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
FcγRIIB as a Key Determinant of Agonistic Antibody Efficacy
Book chapter (August 2014)